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ABSTRACT 
Background:  Adolescent pregnancy is a major public health problem in the United States 
associated with negative sequelae for women, families, and children.  Most of the recent 
decline in adolescent pregnancy in the United States is due to contraception; however the rate 
of adolescent pregnancy in the United States is still higher than in other developed nations.  
Long-acting reversible contraception is underutilized in this respect. 
Purpose:  To review the literature on the outcomes of pregnancy rate, expulsion rate, and 
continuation rate in adolescent women using an IUD for contraception 
Data sources: MEDLINE, ISI Web of Science, and POPLINE searches; relevant reference lists 
Data extraction: 2670 titles and abstracts were reviewed, of which 213 were given full text 
reviews.  13 studies were included in the final review. 
Study selection:  Studies were given relative weight based on the type of study and their 
strength of internal and external validity 
Data synthesis:  The data are mixed for all three primary outcomes of the review with a large 
amount of heterogeneity in types of devices used.  More and higher quality studies are needed 
to determine the effective rates as compared to other contraceptive interventions. 
Conclusion:  The evidence currently available in the literature is currently insufficient to 
ascertain the appropriateness of IUDs as a first-line contraceptive for adolescents. 
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 Teenage pregnancy has many negative consequences to health and society in the 
United States.  Recent declines in teenage pregnancy and birth have most likely been due to an 
increase in the use of contraception by teenagers.  Long-acting reversible contraception, such 
as that provided by the copper and progesterone-secreting intrauterine devices (IUDs), is likely 
the most effective solution for contraception, but these methods have not been adequately 
studied in the teenage population.   
INTRODUCTION 
1. Teenage Pregnancy in the United States 
 Teenage pregnancy has serious personal and societal consequences.  With more than 
half of teenagers in the United States who become pregnant giving birth, this represents a 
substantial number of births: 435,436 in 2006.1  A population-based cohort study found that 
teenage mothers compared to those who become mothers later in life have an increased risk of 
premature death in later life independent of socio-economic status (rate ratio 1.6), meaning 
that reduction of teenage pregnancy and thus birthrate could have a significant positive 
influence on women’s health well beyond the teenage years.2 
 The children of teenage mothers are also at risk of negative health outcomes compared 
to children born to older mothers.  Teenage pregnancy is independently associated with worse 
fetal outcomes, including preterm delivery, low birth weight, and neonatal mortality.3  Teenage 
mothers are more likely to have a diet deficient in micronutrients (such as iron), which may 
explain the increased incidence of small for gestational age infants in children born to teenage 
mothers.4  There are also longer term sequelae for children born to teenage mothers;  being 
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born as result of a teenage pregnancy leads to worse outcomes in adults in various facets of 
health, education, inactivity, and earnings.5 
Despite recent decreases, teenage pregnancy and birth remains a serious problem in 
the United States.   The teenage pregnancy rate (women ages 15-19) reached a peak of 116.9 
per 1,000 women in 1990 and steadily declined through 2005 to 69.5 per 1,000, which 
represents the lowest rate in over 30 years.  However, in 2006 (the last year for which finalized 
data are available), this increased to 71.5 per 1,000.1  Preliminary data for the rate of birth to 
teenage mothers are available through the year 2009, and they show a similar trend to 
pregnancy, with a peak of 61.8 births per 1,000 in 1991 and a decrease through 2005.  There 
was a slight increase through 2006-2007, but this was reversed in 2008 and 2009, with 2009 
having a rate of 39.1 per 1,000 women.6  These encouraging trends belie the fact that the 
United States still has a higher pregnancy and birth rate than those of all European nations, 
including former Soviet bloc nations.7 
 The National Survey of Family Growth (administered by the National Center for Health 
Statistics) periodically conducts a nationally representative survey of women ages 15-44.  As 
part of this survey, respondents are asked questions to determine whether each of their 
pregnancies had been intended or unintended.  Pregnancies are classified as unintended if they 
are either mistimed (the woman would have liked to become pregnant in the future, but did 
not desire pregnancy at that point) or unwanted (the woman did not desire pregnancy at that 
time or in the future).  Pregnancies about which women were indifferent are classified as 
intended.  Based on data from the 2002 survey and using census data as a denominator, Finer 
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and Henshaw estimated that one fifth of all unintended pregnancies in the United States are to 
teenagers, and 82% of all teenage pregnancies are unintended.8   
It must be noted that relative statistics such as the proportion of pregnancies which are 
unintended can be misleading.  For example if the intended pregnancy rate suddenly rose 
without a change in the unintended pregnancy rate, the proportion of unintended pregnancies 
would suddenly drop, without a change in the absolute number.  The data used by Finer and 
Henshaw shows that the 82% statistic may belie the fact that teenage pregnancy rates are 
decreasing for both unintended (from 82 per 1000 to 67 per 1000 from 1994 to 2001) and 
intended pregnancies (from 25 per 1000 to 15 per 1000 during the same time period).8  The 
data also comes from a retrospective survey, which means that recall bias is likely to affect the 
results, and in this case it may underestimate the intendedness of the pregnancy at the time of 
the conception.  An analysis of the 2002 National Survey for Family Growth shows that 
dichotomous classification of pregnancy intendedness is not sufficient to predict pregnancy 
outcomes, and a multidimensional model incorporating aspects such as timing and desire is a 
much stronger predictor.9  Wantedness rather than intendedness may better correlate with 
outcomes; however, dichotomous intendedness outcomes continue to be the main reported 
statistic in this area of consideration.10
,11 
Although it is unclear how large this majority is, and unclear further how important of a 
measure intendedness actually is, the fact that the majority of adolescent pregnancies are 
unintended leads to the conclusion that proximal factors such as adolescent sexual behavior 
are an appropriate point for intervention to decrease teenage pregnancy and birth.  One 
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intervention that has been popular in recent years is abstinence-only or abstinence-based sex 
education in schools; however, this has proven marginally effective at best, with most studies 
showing no effectiveness in decreasing adolescent pregnancy, while comprehensive sex 
education has been more effective.12  This has been corroborated by an analysis of data from 
the 2002 National Survey of Family Growth, which found that those reporting receiving 
comprehensive sex education had a statistically significantly decreased risk of reporting 
adolescent pregnancy compared to those who reported receiving abstinence-only or no sex 
education, between which there was no significant difference.  This was despite no significant 
difference in reported vaginal intercourse.13  It must be taken into consideration that these data 
are from a retrospective study and thus recall bias for all of these statistics is an important 
possibility.  If the association is true, however, the proximal factor likely to have had the largest 
effect on decreasing pregnancy rates is contraception, as reporting of vaginal intercourse was 
not significantly affected by a report of either intervention. 
2. Contraceptives 
According to analyses of data from the 1995 and 2002 National Survey of Family Growth 
by Santelli, et al., the recent decline in teenage pregnancy and births is 86% attributable to 
increased use of contraceptive use, with the rest of the decline attributable to a decrease in 
sexual activity, mostly among women ages 15-17.14,15  The slight increase in teen pregnancy and 
birth rates in 2006 and 2007 was accompanied by a slight decrease in use of contraception as 
measured by the Youth Risk Behavior Survey in those years, with no significant change in sexual 
activity, meaning that decreased contraceptive use is the likely proximal cause for the increased 
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teen pregnancy and birth rates.15 The disparity between teenage pregnancy rates in the United 
States and Europe is also explained by a difference in the rate of contraceptive use.15  Like the 
decreases in teen pregnancy and birth rate in the United States, the decreases in Europe cannot 
be explained by a decrease in sexual activity; in fact, the age at sexual initiation has decreased 
in both the United States and Europe during the same time period.16  Thus, contraception is 
likely the best choice for a proximal intervention to prevent teenage pregnancy and birth, given 
its crucial role in recent decreases in the teen pregnancy and birth rate. 
The 1960s saw the development of two radical and effective methods of birth control.  
In 1960, the FDA allowed the makers of Enovid (an oral combination of an estrogen and a 
progesterone) to market on its contraceptive claims after three years of indication only for 
gynecological disorders.17  In the early 1960s, Gynekoil was introduced as the first mass-
produced intrauterine device (IUD) in the United States, and since that time 8 other IUDs have 
entered the market.18  Since the 1960s, many hormonal and non-hormonal birth control 
methods have been added to the market; a summary of these methods as well as their typical 
and actual use effectiveness rates as determined by systematic review are shown in table 1. 
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Table 1. Methods of contraception currently available in the United States.19 
Method Mechanism of action % of Women with Unintended Pregnancy 
within One Year 
Typical Use Perfect Use 
No method n/a 85% 85% 
Spermicides Spermicidal action of foam/gel/film 
inserted into vagina prior to each 
intercourse 
29% 18% 
Withdrawal Partner ejaculates outside of the 
vagina 
27% 4% 
Fertility awareness-
based methods 
Timing of intercourse based on 
charting of menstrual cycle 
25% 3-5% 
Sponge Combined barrier and spermicidal 
method inserted over the cervix prior 
to intercourse 
32% (parous) 
16% (nulliparous) 
20% (parous) 
9% (nulliparous) 
Diaphragm Barrier method placed over the cervix 
used at each intercourse 
16% 6% 
Condom Barrier method placed in the vagina 
(female) or on the penis (male) used at 
each intercourse 
21% (female) 
15% (male) 
5% (female) 
2% (male) 
Combined pill and 
progestin-only pill 
Daily pill with either estrogen and 
progestin (combined pill) or progestin 
only 
8% 0.3% 
Evra patch Hormonal patch containing estrogen 
and progestins; changed weekly 
8% 0.3% 
NuvaRing Ring containing estrogen and 
progestins inserted into vagina for 
three weeks of each month 
8% 0.3% 
Depo-Provera Injection containing a depot of 
progestin administered every 12 
weeks 
3% 0.3% 
IUD Intrauterine device with either copper 
(copper T) or progestin (LNG-IUS) left 
for either 10 years (copper T) or 5 
years (LNG-IUS) 
0.8% (copper T) 
0.2% (LNG-IUS) 
0.6% (copper T) 
0.2% (LNG-IUS) 
Implanon Plastic rod with progestin inserted into 
subcutaneous tissue and left for 3 
years 
0.05% 0.05% 
Female Sterilization Bilateral tubal ligation performed as a 
permanent surgical procedure 
0.5% 0.5% 
Male Sterilization Both vas deferentia are severed as a 
permanent surgical procedure 
0.15% 0.10% 
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Of the many methods of contraception available, there are currently only two IUDs on the 
market in the United States: a copper-containing IUD, or copper T380A and a progesterone-
secreting IUD, or LNG-IUS.  
3. IUDs Currently on the Market in the United States 
Based on a systematic review of the literature on contraceptive failure, these methods 
are highly effective, with a failure rate of 0.8% for the copper T and 0.2% for LNG-IUS in the first 
year under typical use; with perfect use, the failure rate for the copper T is 0.6%.20  The fact that 
there is little difference in failure rates between perfect and typical use underlines the fact that 
IUDs have the advantage of not requiring patient action each day, and not surprisingly, thus 
prove more effective than typical use of combined oral contraceptive pills (OCPs), which have a 
failure rate of 8% with typical use, and 0.3% with perfect use.20
,21  As well as the advantage of 
being “forgettable” (i.e. requiring no patient action in normal use) LNG-IUS may also hold an 
advantage over OCPs in terms of continuation.  A trial that randomized nulliparous women ages 
18-25 to either OCPs or LNG-IUS found that the continuation rate at one year was higher for 
LNG-IUS than OCPs, with 20% of women discontinuing that IUD and 27% of women 
discontinuing the OCPs.22  A larger prospective cohort study (Contraceptive CHOICE) has found 
that among women given a choice of free contraceptive methods, those who chose the IUDs 
had the highest continuation rates (88% for LNG-IUS, 84% for copper T), as well as higher 
satisfaction compared to OCPs (54% of OCP users were satisfied).23   
Although it is beyond the immediate scope of this review, IUDs also confer non-
contraceptive benefits to women.  For example, the LNG-IUS can be used to treat chronic pelvic 
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pain, and heavy menstrual bleeding, and it has been shown to decrease the risk of endometrial 
cancer.24  The copper-T shows promise as an emergency contraception technique that uniquely 
continues to provide contraceptive benefit, with a failure rate of 0.09% found by a systematic 
review of non-randomized studies.25 
In Europe as in the United States, the dominant method of long-acting reversible 
contraception is the IUD.  All Western European nations, however, have much higher overall 
rates of use, with a full 27% of women using contraception in Norway utilizing an IUD, the 
highest proportion of any nation.26  This difference in IUD use between the United States and 
Western Europe may be partly because provider and public attitudes in the United States 
towards the IUD as birth control were negatively affected by the Dalkon Shield, an aberrant 
device in the 1970s that caused septic miscarriages and was subsequently removed from the 
market.26  After the Dalkon Shield entered and quickly exited the market, the rate of IUD use 
among women in the United States dropped precipitously from a high of nearly 10% of all 
contraceptive users in the early 1970s to a low of 1% of all contraceptive users in 1995, which 
represented the lowest rate of use in any developed nation at that time.27
,28  Since that time, 
there has been an increase in long-acting reversible contraception (LARC) to 5.5% of all 
contraceptive users in 2006-2008, most of which is due to increased use of IUDs, and 
particularly LNG-IUS.27  This increase was most pronounced in women younger than 24 and 
older than 35.  Additionally, those who had first intercourse at age 17 or younger experienced 
an increase in IUD use among users of contraception of 2.5% to 7.8% from 2002 to 2006-200828 
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4. Summary 
In the Contraceptive CHOICE trial, more than 60% of adolescents (69% of participants 
14-17 and 61% of participants 18-20) chose long acting reversible contraception (including both 
IUDs and implantable hormonal birth control) when given a full range of contraceptive 
options.29  A study that compared patient satisfaction with IUDs to patient satisfaction with 
implantable hormonal birth control found that at six months, more women were satisfied with 
the IUD than with the implantable hormonal birth control.30  Despite the popularity of the IUD 
when presented as an option, a survey of adolescents and young women found that only 45.4% 
had heard of the IUD, and a survey of primary care obstetrician-gynecologists found that only 
18% “always” presented the IUD when discussing options for contraception.31
,32  While the 
American Congress of Obstetricians and Gynecologists has issued a Committee Opinion that 
agrees with the World Health Organization’s assessment that IUDs are an appropriate choice of 
contraceptive for adolescents, the most recent systematic review of available data (including 
studies through 2008) shows that the existing literature was promising but insufficient to 
confirm this stance.33,34  Thus, we need a current systematic review of the important clinical 
question: are IUDs an appropriate option for first-line contraception for adolescents in the 
United States? 
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METHODS 
1. Clinical Question 
The focused clinical question that this paper will address is: “Are IUDs an appropriate 
option for first-line contraception for adolescents in the United States?”  For the purposes of 
this systematic review, IUDs will exclude the Dalkon shield as an aberrant device.  The 
comparison was initially to be made to condoms and OCPs, as these are, respectively, the most 
used and second most used contraceptives by adolescents in the United States.35  However, this 
stipulation was abandoned based on the initial lack of appropriate studies in the literature 
search.  Appropriateness will be based on continuation rate, pregnancy rate, and expulsion 
rate.  Adolescents will be defined as females who are 18 years of age or younger. 
Table 2. PICOTS Table of the Clinical Question for this Systematic Review. 
Patient/Problem Adolescent women <22 seeking contraception 
Intervention IUD (except Dalkon Shield or other aberrant device) 
Comparison Any or none 
Outcome Continuation rate, pregnancy rate, and expulsion rate 
Timing of outcome Greater than or equal to 6 months 
Timing of Study No limit 
Studies Randomized (RCT)  and nonrandomized controlled trials, cohort studies, 
case-control studies, case-series 
Setting Primary care setting in any country with a “Very High” Human 
Development ranking 
 
This review originally considered adolescence to be between the ages of 10-21, which is 
the definition typically accepted in pediatrics.36  However, one study found during the literature 
review would have been acceptable other than the inclusion of women up to age 22, and the 
decision was made to raise the limit.  This review will not consider the outcome of satisfaction 
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with the method of contraception, as satisfaction mirrors continuation rate, and continuation 
rate is a more objective measure and thus more likely to be reported and quantified.37  This 
review will not consider the outcome of pelvic inflammatory disease (PID) since PID is rare in 
the United States even in high risk populations receiving IUDs as found by a meta-analysis that 
examined the use of antibiotics in preventing PID as well as an earlier systematic review 
exploring the association between IUD insertion and PID.38,39  Additionally, a previous 
systematic review has shown that while women with a sexually transmitted infection (STI) at 
the time of IUD insertion have an increased risk of PID in comparison to women without a STI at 
the time of IUD insertion, it is unclear whether this represents a risk in IUD insertion itself or an 
increased background risk for women with STIs. 39,40  This review will not consider the effect of 
parity on IUDs in adolescents, instead focusing on the problem of IUDs in adolescents in toto.   
2. Eligibility Criteria  
This review included English language studies with the goal of examining pregnancy rate 
and/or birth control continuation rate and/or IUD expulsion rate in women 21 or younger as 
compared to OCPs or condoms (for pregnancy rate and continuation rate).  Also included were 
studies with a subgroup analysis of a subgroup that is within the definition of an adolescent as 
being from ages 10-22.  The followup period needed to be at least 6 months.  Studies 
conducted at any time were included.  To maximize the number of results, no stipulation was 
made concerning the type of IUD, save that it was not the Dalkon Shield or other aberrant 
device, as a previous review found no studies of the devices currently in use in the United 
States.34  As the review is focusing on the appropriateness of IUDs in adolescents in the United 
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States, at least one of the study settings must be a similarly developed nation.  Developed 
nations for this review will be defined as those on the list of the United Nations’ list of countries 
with a “Very High” rating of Human Development as of 2010, based on the Human 
Development Index which takes into account health, education, and living standards.41  Box 1 
outlines the 43 nations that are included in this definition. 
Box 1. Nations with a Very High Human Development Rating.41 
• Norway 
• Australia 
• New Zealand 
• United States 
• Ireland 
Liechtenstein 
• Netherlands 
• Canada 
• Sweden 
• Germany 
• Japan 
• Korea, 
Republic of 
• Switzerland 
• France 
• Israel 
• Finland 
• Iceland 
• Belgium 
• Denmark 
• Spain 
• Hong Kong, 
China                                      
(SAR)  
• Greece 
• Italy 
• Luxembourg 
• Austria 
• United 
Kingdom 
• Singapore 
• Czech Republic 
• Slovenia 
• Andorra 
• Slovakia 
• United Arab 
Emirates 
• Malta 
• Estonia 
• Cyprus 
• Hungary 
• Brunei 
Darussalam 
• Qatar 
• Bahrain 
• Portugal 
• Poland 
• Barbados 
 
3. Search Strategy 
The author searched PubMed, ISI Web of Science, and Popline to find relevant studies.  All 
searches were designed to broadly capture any article with relevance to IUDs and adolescents.   
The PubMed search involved the use of Medical Subject Heading (MeSH) terms to include any 
documents that had been indexed under “Intrauterine Devices,” which includes both 
medicated and copper devices, as well as “Adolescent” or “Young Adult”, which includes the 
age ranges 13-18 and 19-24, respectively.  The PubMed search also used a broad spectrum of 
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terms which could be construed as fitting either IUD or adolescent in order to include articles 
that had not been indexed to the appropriate MeSH term.  The ISI Web of Science and Popline 
searches both used a similar spectrum of terms.  The PubMed, ISI Web of Science, and Popline 
searches yielded 1852, 278, and 497 records, respectively.  In addition to this search strategy, 
the bibliography of the only previous systematic review of this topic in the literature was 
examined.  This article included 43 citations.  The actual strategies and results are shown in 
table 3. 
Table 3. Search Strategies and Results. 
Source Search Strategy Records* Full Text 
Reviewed* 
Met Criteria* 
PubMed 
MEDLINE 
(Limits 
activated: 
English) 
("Intrauterine Devices"[Mesh] OR IUD 
OR IUCD OR IUS OR intrauterine 
contracepti* OR intrauterine system* 
OR intrauterine device*) AND 
("Adolescent"[Mesh] OR 
"Students"[Mesh] OR "Young 
Adult"[Mesh] OR adolescen* OR 
student* OR teen* OR youth) 
1852 162 14 
ISI Web of 
Science 
(IUD* OR IUS OR IUCD* OR 
intrauterine device* OR intrauterine 
system* OR intrauterine contracepti*) 
AND (adolescen* OR youth OR 
student* OR teen*) 
278 24 8 
Popline (IUD*/IUS/IUCD*/intrauterine 
device*/intrauterine 
contracepti*/intrauterine system*) & 
(adolescen*/teen*/youth/student*) 
497 14 4 
Deans and 
Grimes. 
“Intrauterine 
devices for 
adolescents: a 
systematic 
review” 
Bibliography review 43 13 7 
 
 
 
 
*Note: there was overlap between the sources in all of these categories. 
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4. Quality Criteria 
The original intent of the review was to exclude case studies, case series, and, case-control 
studies in favor of controlled trials and cohort studies, since cohort studies provide a greater 
level of evidence (Level 3; Level 2 if the study is well-conducted and demonstrates a dramatic 
effect) than do case-control studies (Level 4) according to Oxford’s Centre for Evidence Based 
Medicine (OCEBM).42  The levels of evidence for treatment benefits and harms according to 
OCEBM are illustrated in table 3.  However, due to the relative dearth of the literature on this 
subject, descriptive studies were included in the review.   
Table 3: Levels of Evidence for Treatment Benefits and Treatment Harms.42 
 Treatment Benefits Treatment Harms 
 Common Rare 
Level 1 Systematic review of 
randomized trials or n-of-1 
trials 
Systematic review of 
randomized trials, 
systematic review of nested 
case-control studies, n-of-1 
trial with the patient you are 
raising the question about, 
or observational study with 
dramatic effect 
Systematic review of 
randomized trials or n-of-1 
trial 
Level 2 Randomized trial or 
observational study with 
dramatic effect 
Individual randomized trial 
or (exceptionally) 
observational study with 
dramatic effect 
Randomized trial or 
(exceptionally observational 
study with dramatic effect 
Level 3 Non-randomized controlled 
cohort/follow-up study 
Non-randomized controlled cohort/follow-up study (post-
marketing) surveillance) provided there are sufficient 
numbers to rule out a common harm (for long-term harms 
the duration of follow-up must be sufficient) 
Level 4 Case-series, case-control 
studies, or historically 
controlled studies 
Case-series, case-control, or historically controlled studies 
Level 5 Mechanism-based reasoning Mechanism-based reasoning 
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This review used the United States Preventive Services Task Force’s (USPSTF) guidelines for 
assessing the internal validity of all comparative studies.  The criteria used for the guidelines are 
specific to each study type, with randomized controlled trials and cohort studies having nearly 
identical criteria except for those which account for their mechanistic differences.   A study 
received a rating of “good” if it met all criteria and maintained appropriate follow-up, “fair” if it 
had any of the problems listed in Table 4 but no flaw fatal enough to invalidate the results, or 
“poor” if there were flaws in the study that were fatal enough to invalidate the results.43  The 
criteria and the rating system are outlined in box 2 and table 5.  The internal validity of the 
case-series was also assessed along a good/fair/poor gradient based on author’s judgment, as 
there are no specific USPSTF criteria for case-series since no comparison is being made. 
Box 2: USPSTF Minimal Criteria for Randomized Controlled Trials and Cohort Studies.43 
• Initial assembly of comparable groups: 
o For RCTs: adequate randomization, including first concealment and whether 
potential confounders were distributed equally among groups. 
o For cohort studies: consideration of potential confounders with either restriction 
or measurement for adjustment in the analysis; consideration of inception 
cohorts 
• Maintenance of comparable groups (includes attrition, cross-overs, adherence, 
contamination). 
• Important differential loss to follow-up or overall high loss to follow-up 
• Measurements: equal, reliable, and valid (includes masking of outcome assessment). 
• Clear definition of interventions. 
• All important outcomes considered. 
• Analysis: adjustment for potential confounders for cohort studies, or intention to treat 
analysis for RCTs 
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Table 5: USPSTF Internal Validity Ratings for RCTs and Cohort Studies.43 
Good rating Meets all criteria: Comparable groups are assembled initially and maintained 
throughout the study (follow-up at least 80 percent); reliable and valid 
measurement instruments are used and applied equally to the groups; 
interventions are spelled out clearly; all important outcomes are considered; and 
appropriate attention to confounders in analysis. In addition, for RCTs, intention 
to treat analysis is used. 
Fair rating Studies will be graded "fair" if any or all of the following problems occur, without 
the fatal flaws noted in the "poor" category below: Generally comparable groups 
are assembled initially but some question remains whether some (although not 
major) differences occurred with follow-up; measurement instruments are 
acceptable (although not the best) and generally applied equally; some but not 
all important outcomes are considered; and some but not all potential 
confounders are accounted for. Intention to treat analysis is done for RCTs. 
Poor rating Studies will be graded "poor" if any of the following fatal flaws exists: Groups 
assembled initially are not close to being comparable or maintained throughout 
the study; unreliable or invalid measurement instruments are used or not 
applied at all equally among groups (including not masking outcome 
assessment); and key confounders are given little or no attention. For RCTs, 
intention to treat analysis is lacking. 
 
 In addition to considering internal validity, the review also assessed the external validity 
of the studies using the USPSTF’s criteria for generalizability and criteria for assessing external 
validity.44  The external validity of all included studies was assessed as compared to the source 
population in the United States.  A study received a rating of “good” if it minimally differed 
from the generalizability requirements with regards to the study’s population, situation, and 
providers.  A study received a rating of “fair” if it moderately differed from the generalizability 
requirements with regards to the study’s population, situation, and providers.  A study received 
a rating of “poor” if it majorly differed from the generalizability requirements with regards to 
the study’s population, situation, and providers.  Table 6 illustrates the USPSTF ratings system 
for external validity. 
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Table 6: USPSTF External Validity Ratings.44 
Good The study differs minimally from the US primary care population/situation/providers 
and only in ways that are unlikely to affect the outcome; it is highly probable (>90%) 
that the clinical experience with the intervention observed in the study will be attained 
in the US primary care setting. 
Fair The study differs from the US primary care population/situation/providers in a few ways 
that have the potential to affect the outcome in a clinically important way; it is only 
moderately probable (50-89%) that the clinical experience with the intervention in the 
study will be attained in the US primary care setting 
Poor The study differs from the US primary care population/situation/providers in many 
ways that have a high likelihood of affecting the clinical outcomes; the probability is low 
(<50%) that the clinical experience with the intervention observed in the study will be 
attained in the US primary care setting. 
 
5. Study Selection 
The titles and abstracts of the articles identified through the search strategy were reviewed 
by the author.  If it was absolutely clear from the title and/or abstract that the given article met 
exclusion criteria, the article was discarded; every effort was made for a sensitive rather than a 
specific approach to abstract and title review.  The articles that remained after this exclusion 
process were given a full text review.  Articles in which full text review did not reveal any 
exclusion criteria were included in the abstraction process for systematic review. 
6. Abstraction Process 
The author performed the data abstraction solely for the articles that were selected for the 
systematic review after full text review using a standard form for each study.  The following 
information was extracted for each study: general information (including citation and country 
of origin), study question, source of funding, source population, study population, design, 
 19 
 
intervention, comparison, potential for selection bias, population characteristics (including 
randomization and group similarity), outcome assessment, measurement, potential for 
measurement bias, potential for confounding, type of analysis, results, attrition (number of 
dropouts), overall judgment of internal validity, and external validity.  Table 7 illustrates the 
standard data extraction form used. 
Table 7. Example Data Extraction Form. 
Study JAMA Citation:  
Country:  
Study Question:  
Source of Funding:  
Source Population:  
Study Population:  
Exclusion criteria:  
Design: Study design:  
Sample size:  
Intervention: Type of IUD?  
Comparison:  
Potential for Selection Bias:  
Population Characteristics: Parity:  
Randomization?  
Groups similar at baseline?  
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate?  
--Timing?  
Cumulative expulsion rate?  
--Timing?  
Continuation rate?  
--Timing?  
Measurement Study groups: 
 
Exposure measures: 
Outcomes:  
Outcome measures:  
Potential for Measurement Bias:  
Potential for Confounding:  
Analysis:  
Results: Unintended pregnancy rate:  
Cumulative expulsion rate:  
Continuation rate:  
Attrition: Number of dropouts? 
Overall Judgment of Internal 
Validity (Quality Rating): 
 
External Validity:  
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7. Synthesis of Evidence 
As this review assesses a topic on which the vast majority of the literature is non-
randomized and focused on a very heterogeneous group of devices which are not currently in 
use in the United States, a meta-analysis based on pooled data is not appropriate at this time.  
The evidence extracted from each study will be entered into template with a narrative 
interpretation of the results for each study.  An example of the template is shown in table 8.  
The templates will then be combined into a single table, and the overall evidence profile of all 
studies will be performed for each of the primary outcomes for this review: pregnancy rate, 
expulsion rate, and continuation rate.  In synthesizing the final results for the review, attention 
will be paid to the results of the studies, as well as their respective size, type, and quality. 
Table 8. Template for Synthesis of Studies. 
Citation Number of 
participants 
Ages Parity Internal 
Validity 
External 
Validity 
IUDs 
used 
Results Timing 
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RESULTS 
1. Study Selection 
A total of 2670 title/abstract combinations were reviewed based on the results of the 
literature search.  Of these 2670 articles, 213 underwent full text review.  Of the 213 which 
underwent full text review, 13 met the final inclusion criteria for the systematic review.  Of 
these 13, there were 5 cohort studies, 6 case-series, 1 randomized controlled trial, and 1 
synthesis of pooled data from multiple trials,   Figure 1 illustrates the flow of information 
through the phases of the review, and summarizes the reasons for exclusion based on full text 
review.   
Figure 1. PRISMA Diagram.  
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 Studies were reviewed in alphabetical order by first author last name.  Full data 
extraction tables are included in Appendix A. 
Study 1 
Citation Behringer T, Reeves MF, Rossiter B, Chen BA, Schwarz EB. Duration of 
use of a levonorgestrel IUS amongst nulliparous and adolescent 
women. Contraception. 2011;84(5):e5-e10. 
Study Design Retrospective cohort 
Study population  
(number, ages, 
parity)  
131 adolescents, ages 14-20, 18.3% nulliparous 
697 adult women ages 21-50, 11.5% nulliparous  
Length of follow-up 36 months 
IUDs used LNG-IUS 
Internal validity Fair 
External validity Fair 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
Not measured  
9.9% at 36 months 
80.9% at 36 months 
  
 The Behringer et al. study, “Duration of use of a levonorgestrel IUS amongst nulliparous 
and adolescent women” is a retrospective cohort published in Contraception in 2011.  
Participants were selected by retrospective chart review of women aged 14-50 years old seen in 
an academic clinic in Pittsburgh, PA and receiving an LNG-IUS for contraception, dysmenorrhea, 
or menorrhagia between June 2005 and April 2008.  In this study, women from 14-20 were 
considered to be adolescents.  There were 131 adolescents, of which 18.3% were nulliparous.  
The clinical outcomes of adolescents and adults were compared, as were the clinical outcomes 
of nulliparous patients and parous patients.45 
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The internal validity of the study was deemed to be “fair” based on the moderate 
potential for selection bias and confounding, and low to moderate potential for measurement 
bias.  The external validity of the study was deemed to be “fair” as it was not clear that the 
source population is highly comparable to the primary care population of the United States.   
Although adolescents had a non-statistically significant higher expulsion rate (9.9% vs. 5.4%), 
the adolescent group was found to have no statistically significant difference in expulsion rate 
or continuation rate at 36 months as compared to adult women (aged 21-50) based on hazard 
ratios which controlled for confounders.   
Study 2 
Citation Godfrey EM, Memmel LM, Neustadt A, et al. Intrauterine contraception 
for adolescents aged 14-18 years: A multicenter randomized pilot study 
of levonorgestrel-releasing intrauterine system compared to the 
copper T 380A. Contraception. 2010;81(2):123-127. 
Study Design Randomized controlled trial 
Study population  
(number, ages, 
parity)  
23 women, ages 14-18, 12 nulliparous  
Length of follow-up 6 months 
IUDs used Copper-T380A (11 participants), LNG-IUS (12 participants)  
Internal validity Fair 
External validity Fair 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
N = 0 in LNG-IUS, N = 1 in copper-T380A at 6 months 
N = 0 in LNG-IUS, N = 2 in copper-T380A at 6 months 
75% (N = 9 of 12) in LNG-IUS, 45% (N = 5 of 11) in copper-T380A 
 
 The Godfrey et al. study “Intrauterine contraception for adolescents aged 14-18 years: A 
multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared 
to the copper T 380A is a single-blind randomized controlled trial published in Contraception in 
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2010.  Participants were selected from patients seen in an academic family planning and family 
medicine clinic in Chicago.  Of the 37 approached, 23 were eligible and randomized to either 
LNG-IUS (12 patients) or copper-T 380A (11 patients).  The patients were blinded to the 
intervention, but the investigators and study coordinators were not.  The clinical outcomes of 
the two groups were compared.46 
 The internal validity of this study was deemed to be “fair” based on the moderate to low 
potential for selection bias, measurement bias, and confounding.  The external validity of this 
study was deemed to be “fair” based on the fact that although the study population likely was 
characteristic of the United States primary care population, the study size was too small to be 
able to draw definitive conclusions.  The study found no statistically significant difference in 
pregnancy rate, cumulative expulsion rate, or continuation rate at 6 months between users of 
the LNG-IUS and users of the copper T 380A. 
Study 3  
Citation Goldman JA, Dekel A, Reichman J. Immediate postabortion intrauterine 
contraception in nulliparous adolescents. Isr J Med Sci. 1979;15(6):522. 
Study Design Prospective cohort 
Study population  
(number, ages, 
parity)  
162 women, ages 13-18, all nulliparous (126 primigravid, 36 
multigravid) 
Length of follow-up 12 months 
IUDs used Lippes loop A, copper-7, copper-T  
Internal validity Poor 
External validity Poor 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
3.7% for all methods 
11.1% for all methods 
69.1% for all methods 
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 The Goldman et al. study “Immediate postabortion intrauterine contraception in 
nulliparous adolescents” was published in the Israeli Journal of Medical Science in 1979.  In this 
prospective cohort study, 300 pregnant teenagers (ages 13-18) referred for abortion were 
offered immediate postabortion intrauterine contraception.  162 adolescents consented to the 
study.  56 were allocated to the Lippes loop A, 45 to the copper-7, and 61 to the copper-T.  
Clinical outcomes of pregnancy rate, expulsion rate, and continuation rate were obtained for 
both the individual devices and the overall study population.47 
 The internal validity of this study was deemed to be “poor” due to the high potentials 
for selection bias, measurement bias, and confounding.  The external validity of this study was 
deemed to be “poor” due to the lack of information regarding characteristics of those who did 
and did not participate in the study.   The study found an unintended pregnancy rate of 3.7% at 
12 months for all methods, a cumulative expulsion rate of 11.1% at 12 months for all methods, 
and a continuation rate of 69.1% at 12 months for all methods. 
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Study 4 
Citation Goldman JA, Reichman J. Contraception in the teenager. A comparison of four 
methods of contraception in adolescent girls. Isr J Med Sci. 1980;16(7):510. 
Study Design Prospective cohort 
Study population  
(number, ages, 
parity)  
160 women, ages 14-18, all nulliparous  
N = 72 receiving OCPs 
N = 30 receiving IUD 
N = 38 advised to use condoms 
N = 20 receiving contraceptive foam 
Length of follow-up 24 months 
IUDs used Copper-7, copper-T 
Internal validity Poor 
External validity Poor 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
N = 1 of 30 at 24 months 
N = 2 of 30 at 24 months 
73.3% at 24 months 
 
 The Goldman and Reichman study “Contraception in the teenager. A comparison of four 
methods of contraception in adolescent girls” is a prospective cohort study published in the 
Israeli Journal of Medical Science in 1980.  Participants were selected from women aged 14-18 
“of high socioeconomic standing” who were referred to a clinic or private practitioner by their 
parents or school nurse following request for contraception.  160 adolescents were enrolled, 
and given access to and counseling on four contraceptive methods: OCPs., IUD, condoms, and 
contraceptive foam.  72 chose OCPs, 30 chose IUDs, 38 chose condoms, and 20 chose 
contraceptive foam.  Clinical outcomes at 24 months were then compared amongst the 
groups.48 
 The internal validity of this study was deemed “poor” due to high potential for selection 
bias, measurement bias, and confounding.  External validity was deemed “poor” as it was 
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unclear exactly what characteristics were of the source population, and how participants were 
selected from the source population.  The study found 1 unintended pregnancy (of 30 
participants receiving IUD) at 24 months, compared to 0 (of 72) for OCPs, 2 (of 38) for condoms, 
and 1 (of 20) for foam.  There were 2 expulsions (of 30 receiving the IUD) of the IUD at 24 
months.  There was a continuation rate of 73.3% at 24 months for IUDs, compared to 72% for 
OCPs, 78.9% for condoms, and 15.8% for contraceptive foam. 
Study 5 
Citation Hirvonen E, Kaivola S. A new copper IUD (Fincoid) in adolescent and young 
nulliparous women. Contracept Deliv Syst. 1983;4:149. 
Study Design Case-series 
Study population  
(number, ages, 
parity)  
241 women, ages 15-21, all nulliparous 
Length of follow-up 12 months 
IUDs used Fincoid 
Internal validity Poor 
External validity Poor 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
4.2 per 100 women at 12 months 
1.9 per 100 women at 12 months 
73.1% at 12 months 
 
.The Hirvonen and Kaivola study “A new copper IUD (Fincoid) in adolescent and young 
nulliparous women” is a case-series published in Contraceptive Delivery Systems in 1983.  241 
adolescents aged 15-21 were recruited from adolescents seeking contraception at an 
outpatient clinic in Helsinki in whom OCPs had caused side-effects or were contraindicated.  
The study participants received the Fincoid IUD, and clinical outcomes were assessed after 12 
months.49  
 28 
 
The internal validity of this study was deemed “poor” due to the high potential for 
selection bias, and measurement bias.  The external validity of this study was deemed “poor” 
due to the lack of information about the source population.  The unintended pregnancy rate 
was 4.2 per 100 women at 12 months, the cumulative expulsion rate was 1.9 per 100 women at 
12 months, and the continuation rate was 73.1% at 12 months. 
Study 6 
Citation Jorgensen V. One-year contraceptive follow-up of adolescent patients. Am J 
Obstet Gynecol. 1973;115(4):484. 
Study Design Prospective cohort 
Study population  
(number, ages, 
parity)  
184 women, ages 11-17, all parous 
N = 90 selecting OCPs 
N = 82 selecting IUD 
N = 2 selecting diaphragm 
Length of follow-up 12 months 
IUDs used Lippes loop, copper-T 
Internal validity Poor 
External validity Poor 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
5 of 184 at 12 months (all methods) 
5 of 82 IUDs at 12 months 
88% for IUD 
 
 The Jorgensen study “One-year contraceptive follow-up of adolescent patients” is a 
prospective cohort study published in the American Journal of Obstetrics and Gynecology in 
1973.  221 “high risk” postpartum women seen in an adolescent obstetrics and gynecology 
clinic were assessed for eligibility, and 213 were given 5 weeks of OCPs for the interim between 
discharge and 5 week follow-up.  At the 5 week follow-up, 184 returned to clinic and selected 
either OCPs, IUD, or diaphragm.  Clinical outcomes were then assessed.50 
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 The internal validity of this study was deemed “poor” due to moderate to high potential 
for selection bias and measurement bias and high potential for confounding.  The external 
validity of this study was deemed “poor” due to the lack of information concerning the source 
population.  There were 5 overall pregnancies in the study group at 12 months (of 184 
participants using all methods).  The cumulative expulsion was 5 (of 82 IUD users) at 12 months, 
and the continuation rate was 88% for IUDs vs. 70% for OCPs at 12 months. 
Study 7 
Citation Kulig JW, Rauh JL, Burket RL, Cabot HM, Brookman RR. Experience with the 
copper 7 intrauterine device in an adolescent population. J Pediatr. 
1980;96(4):746. 
Study Design Case-series 
Study population  
(number, ages, 
parity)  
120 participants, ages 13-22, 81% nulliparous 
Length of follow-up 36 months 
IUDs used Copper-7 
Internal validity Poor 
External validity Fair 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
3 of 120 at 36 months (2.0 per 100 woman-years of IUD insertion) 
18% expulsion rate at 36 months 
39% continuation rate at 36 months 
 
 The Kulig et al. study “Experience with the copper 7 intrauterine device in an adolescent 
population” is a case-series published in the Journal of Pediatrics in 1980.  Participants were 
selected from adolescent patients seen in the Cincinnati Adolescent Clinic choosing an IUD for 
contraception from 7/1974 to 6/1978.  There were 120 participants, all of whom received the 
copper-7 IUD.  Clinical outcomes were assessed at 36 months.51 
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 The internal validity of this study was deemed “poor” due to moderate to high potential 
for selection bias and measurement bias.  The external validity of this study was deemed “fair” 
since the sample was likely broadly representative of the U.S. primary care population.  The 
study found that n = 3 of 120 had an unintended pregnancy at 36 months, that the cumulative 
expulsion rate was 18% at 36 months, and that the continuation rate was 39% at 36 months. 
Study 8 
Citation Lane ME, Sobrero AJ. Experience with intrauterine contraception by 
adolescent women. Mt Sinai J Med. 1975;42(4):337. 
Study Design Case-series 
Study population  
(number, ages, 
parity)  
101 patients, ages 13-19, 96% nullilparous 
Length of follow-up 9 months 
IUDs used Loop C, Loop D, LEM, W 
Internal validity Fair 
External validity Poor 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
N = 4 at 9 months 
N = 21 at 9 months 
73.2% at 9 months 
 
 The Lane and Sobrero study “Experience with intrauterine contraception by adolescent 
women” is a case-series published in the Mount Sinai Journal of Medicine in 1975.  Of 399 
adolescent patients aged 13-19 seen at the Margaret Sanger Teen Center from 3/1971-
12/1972, 101 selected the IUD as their contraceptive method.  The patients were fitted with 
one of four devices: either Loop C (N = 44), Loop D (N = 1), LEM (N = 54), or W (N = 2).  The 
patients were followed for 9 months.52 
 31 
 
 The internal validity of the study was deemed “fair” due to a low number of dropouts, 
as well as a moderate potential for measurement bias and moderate potential for selection 
bias.  The external validity of the study was deemed “poor” because of a lack of information 
about the source population and how it relates to the U.S. primary care population.  The study 
found N = 4 (of 101) unintended pregnancies at 9 months, an N = 21 (of 101) expulsions at 9 
months, and a continuation rate of 73.2% at 9 months. 
 Study 9 
Citation Larsson B, Hagström B, Viberg L, Hamberger L. Long-term clinical experience 
with the Cu-7-IUD. Evaluation of a prospective study. Contraception. 
1981;23(4). 
Study Design Prospective cohort 
Study population  
(number, ages, 
parity)  
179 women, ages 15-19 
1267 women, ages 20-49 
Overall parity: 59 nulliparous (unclear how this was stratified by age) 
Length of follow-up 24 months 
IUDs used Copper-7 
Internal validity Poor 
External validity Poor 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
6.1% at 24 months for 15-19 
12.9% at 24 months for 15-19 
77.2% at 24 months for 15-19 
 
 The Larsson et al. study “Long-term clinical experience with the Cu-7-IUD. Evaluation of 
a prospective study” is a prospective cohort published in Contraception in 1981.  1446 women 
aged 15-49 receiving contraception at a private clinic in Stockholm or one of two family 
planning centers in Huddinge from 1971-1979 were selected for the study, of which 179 were 
adolescents aged 14-19.  The participants who elected for IUDs received the copper-7 IUDs, and 
comparisons of clinical outcomes were made between the different age groups.53 
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 The internal validity of the study was deemed “poor” based on the high potential for 
selection bias, measurement bias, and confounding.  The external validity of the study was 
deemed “poor” based on the lack of information on the characteristics of the source 
population.  The study found a pregnancy rate of 6.1% at 24 months in those ages 15-19; this 
was higher, but not statistically significantly higher than that found in those ages 20-49 (1.4-
5.4%).  There was a cumulative expulsion rate of 12.9% at 24 months in those ages 15-19, which 
was statistically significantly higher than the expulsion rate of those ages 20-49 (p < 0.05 vs. 20-
24 and p < 0.01 vs. 25-49).  The continuation rate for those aged 15-19 was 77.2% at 24 months, 
but was not analyzed with respect to significant differences with the other age groups. 
Study 10 
Citation Patchen L, Berggren EK. Use of the copper T380A intrauterine device by 
adolescent mothers: Continuation and method failure J Pediatr Adolesc 
Gynecol. 2011;24(2):71-73. 
Study Design Retrospective case-series 
Study population  
(number, ages, 
parity)  
39 women, ages 15-21, all parous 
Length of follow-up 24 months 
IUDs used Copper-T 380A 
Internal validity Fair 
External validity Poor 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
10% at 24 months 
15% at 24 months 
39% at 24 months 
 
 The Patchen and Berggren study “Use of the copper T380A intrauterine device by 
adolescent mothers: Continuation and method failure” is a retrospective case-series published 
in the Journal of Pediatric and Adolescent Gynecology in 2011.  The charts of 318 adolescent 
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mothers aged 15-21 participating in a teen secondary pregnancy prevention program who had 
delivered prior to age 18 were reviewed.  Of these 318, 39 had a copper-T 380A IUD inserted as 
a contraceptive and were included in the study; 93% were Hispanic.  Outcomes at 24 months 
post-insertion were determined by chart review.54 
 The overall judgment of internal validity was deemed “fair” because of a moderate 
potential for measurement bias and a moderate potential for selection bias.  The overall 
judgment of external validity was deemed “poor” as the study population was small and likely 
not representative of the U.S. primary care population.  The study found an unintended 
pregnancy rate of 10% at 24 months, a cumulative expulsion rate of 15% at 24 months, and a 
continuation rate of 39% at 24 months. 
Study 11 
Citation Paterson H, Ashton J, Harrison-Woolrych M. A nationwide cohort study of the 
use of the levonorgestrel intrauterine device in New Zealand adolescents 
Contraception. 2009;79(6):433-438 
Study Design Retrospective case-series 
Study population  
(number, ages, 
parity)  
133 responders to questionnaire, ages 10-19, n = 114 nulligravid 
Length of follow-up 12 months 
IUDs used LNG-IUS 
Internal validity Fair 
External validity Fair 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
N = 0; time unspecified 
N = 11; time unspecified 
85% at 12 months 
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 The Paterson et al. study “A nationwide cohort study of the use of the levonorgestrel 
intrauterine device in New Zealand adolescents” is a retrospective case-series published in 
Contraception in 2009.  Despite being named a cohort study, the design was that of a case-
series as there was no comparison group.  177 adolescents 10-19 were identified as having 
received the LNG-IUS through New Zealand’s Intensive Medicine Monitoring Program, and of 
those, 133 were included in the study based on response to a questionnaire sent to their 
provider.55 
 The internal validity was deemed “fair” due to a moderate potential for selection bias 
and a moderate potential for measurement bias.  The external validity was deemed “good” as 
this study represented a broad sample of adolescents throughout a developed nation.  The 
study found no pregnancies in the study population, although time period for this was not 
specified, and the study was not powered to assess pregnancy rate.  The study found a 
“cumulative incidence” of 11 expulsions in the 133 patients; however, this was not given a time 
period and thus is not a true measure of incidence.  The study found a continuation rate of 85% 
at 12 months. 
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Study 12 
Citation Sivin I, Stern J. Long-acting, more effective copper T IUDs: A summary of U.S. 
experience, 1970-75. Stud Fam Plann. 1979;10(10). 
Study Design Pooled data from random assignment and cohort studies 
Study population  
(number, ages, 
parity)  
N = 706 women <20 receiving TCu 380A 
N = 2830 women >20 receiving TCu 380A 
N = 465 women <20 receiving TCu 220C 
N = 1385 women >20 receiving TCu 220C 
N = 2280 women <20 receiving TCu 200 
N = 7558 women >20 receiving TCu 200 
 
Parity for TCu 200 acceptors was 42.8%, parity for TCu 380A acceptors was 
63.7%, and parity for TCu 220C acceptors was 70.3%; no information 
regarding parity by age group 
Length of follow-up 24 months 
IUDs used Copper-T 200, copper-T 380A, copper-T 220C 
Internal validity Poor 
External validity Fair 
Results: 
   Pregnancy rate: 
 
 
   Expulsion rate: 
 
 
   Continuation rate 
For women <20: 
1.0 per 100 acceptors for TCu 380A at 24 months 
2.2 per 100 acceptors for TCu 220C at 24 months 
6.6 per 100 acceptors for TCu 200 at 24 months 
14.6 per 100 acceptors for TCu 380A at 24 months 
12.6 per 100 acceptors for TCu 220C at 24 months 
17.5 per 100 acceptors for TCu 200 at 24 months 
Not stratified by age 
 
 The Sivin and Stern study, “Long-acting, more effective copper T IUDs: A summary of 
U.S. experience, 1970-75” is an analysis of pooled data from 42 random assignment and cohort 
studies that was published in Studies in Family Planning in 1979.  This study selected studies 
carried out in the U.S. (with one in Canada) on three models of copper IUDs, with the exclusion 
criteria that none of the included studies have a dropout rate over 30%.  These data were 
stratified by multiple characteristics, including age (with a stratum of <20), and the results were 
reported.56 
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 The internal validity of the study was deemed “poor” due to high potential for selection 
bias, moderate to high potential for measurement bias, and high potential for confounding.  
The external validity of the study was deemed “fair” due to the large amount of aggregate data 
on thousands of women, which in sum are more likely to represent the U.S. population than 
any individual study.  For women <20, the 24 month rate of unintended pregnancy was 1.0 per 
100 acceptors for TCu 380A, 2.2 per 100 acceptors for TCu 220C, and 6.6 per 100 acceptors for 
TCu 200.  Also for women <20, the 24 month rate of expulsion was 14.6 per 100 acceptors for 
TCu 380A, 12.6 per 100 acceptors for TCu 220C, and 17.5 per 100 acceptors for TCu 200. 
Study 13 
Citation Weiner E, Berg AA, Johansson I. Copper intrauterine contraceptive devices in 
adolescent nulliparae. Br J Obstet Gynaecol. 1978;85(3):204. 
Study Design Prospective case-series 
Study population  
(number, ages, 
parity)  
243 women, ages 13-20, all nulligravidae 
Length of follow-up 6 months 
IUDs used Copper-T 200 and copper-7 
Internal validity Poor 
External validity Poor 
Results: 
   Pregnancy rate: 
   Expulsion rate: 
   Continuation rate 
 
2% at 6 months 
11.5% at 6 months 
78.8% at 6 months 
 
The Weiner et al. study “Copper intrauterine devices in adolescent nulliparae” is a 
prospective case-series published in the British Journal of Obstetrics and Gynaecology in 1978.  
The patients were drawn from a group of 772 women in Sweden aged 13-20 seeking 
contraception at the Department of School Health in Uppsala Sweden from 3/1973-6/1975.  
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The study population was the 243 patients from that group that elected to receive an IUD.  
Clinical outcomes were then assessed at 6 months.57 
The internal validity of this study was deemed to be “poor” due to high potential for 
selection bias and moderate to high potential for measurement bias.  The external validity of 
this study was deemed to be “poor” due to lack of characteristic information about the source 
population.  At 6 months, the unintended pregnancy rate was 2%, the cumulative expulsion 
rate was 11.5%, and the continuation rate was 78.8%. 
Synthesis of the Evidence 
 Of the 13 studies, none had “good” internal or external validity.  Three studies had “fair” 
internal and external validity.  Two studies had “poor” internal validity and “fair” external 
validity.  Two studies had “fair” internal validity and “poor” external validity.  Two studies had 
“poor” internal validity and “fair” external validity.  Six studies had “poor” internal and external 
validity. 
 The IUDs used in the studies included the LNG-IUS, copper-T 380A, Lippes loop A, 
copper 7, Fincoid, Lippes loop C, Lippes loop D, LEM, W, copper-T 220C, and copper-T 200.  Of 
these devices, only two (LNG-IUS and copper-T 380A) are currently approved for use in the 
United States.  Eight studies included at least one of those two methods.  Only three contained 
only methods currently available in the United States.  There was substantial heterogeneity in 
the results of the studies as well.  Tables 9-11 provide a summary of each of the three primary 
outcomes being assessed in this systematic review. 
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Table 9. Pregnancy Rates. 
Citation N = ? Ages Parity Internal 
Validity 
External 
Validity 
IUDs 
used 
Pregnancy 
rate 
Timing 
Behringer, et 
al.
45
 
131 14-20 18.3% 
nulliparou
s 
Fair Fair LNG-IUS Not 
measured 
36 months 
Godfrey, et 
al.
46
 
12 
11 
14-18 12 
nulliparou
s 
Fair Fair LNG-IUS 
TCu 380A 
N = 0 
N = 1 
6 months 
Goldman, et 
al.
47
 
162 13-18 100% 
nulliparou
s 
Poor Poor Lippes 
loop A, 
Cu-7, TCu 
3.7% 12 months 
Goldman 
and 
Reichman
48
 
30 14-18 100% 
nulliparou
s 
Poor Poor Cu-7, TCu N = 1 24 months 
Hirvonen 
and Kaivola
49
 
241 15-21 100% 
nulliparou
s 
Poor Poor Fincoid 4.2 per 
100 
12 months 
Jorgensen
50
 82 11-17 100% 
parous 
Poor Poor Lippes 
loop, TCu 
Not 
measured 
for 
subgroup 
12 months 
Kulig, et al.
51
 120 13-22 81% 
nulliparou
s 
Poor Fair Copper-7 N = 3 
2.0 per 
100 
woman-
years 
36 months 
Lane and 
Sobrero
52
 
101 13-19 96% 
nulliparou
s 
Fair Poor Loop C, 
Loop D, 
LEM, W 
N = 4 9 months 
Larsson, et 
al.
53
 
179 15-19 Unclear Poor Poor Copper-7 6.1% 24 months 
Patchen and 
Berggren
54
 
39 15-21 100% 
parous 
Fair Poor TCu 380A 10% 24 months 
Paterson, et 
al.
55
 
133 10-19 N = 114 
nulligravid 
Fair Fair LNG-IUS N = 0 Not 
specified 
Sivin and 
Stern 
706 
465 
2280 
<20 Unclear Poor Fair TCu 380A 
TCu 220C 
TCu 200 
1.0/100 
2.2/100 
6.6/100 
24 months 
Weiner, et 
al.
57
 
243 13-20 100% 
nulligravid
ae 
Poor Poor TCu 200, 
Copper-7 
2% 6 months 
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Table 10. Expulsion Rates. 
Citation N = ? Ages Parity Internal 
Validity 
External 
Validity 
IUDs 
used 
Expulsion 
Rate 
Timing 
Behringer, et 
al.
45
 
131 14-20 18.3% 
nulliparou
s 
Fair Fair LNG-IUS 9.9% 36 months 
Godfrey, et 
al.
46
 
12 
11 
14-18 12 
nulliparou
s 
Fair Fair LNG-IUS 
TCu 380A 
N = 0 
N = 2 
6 months 
Goldman, et 
al.
47
 
162 13-18 100% 
nulliparou
s 
Poor Poor Lippes 
loop A, 
Cu-7, TCu 
11.1% 12 months 
Goldman 
and 
Reichman
48
 
30 14-18 100% 
nulliparou
s 
Poor Poor Cu-7, TCu N = 2 of 30 24 months 
Hirvonen 
and Kaivola
49
 
241 15-21 100% 
nulliparou
s 
Poor Poor Fincoid 1.9 per 
100 
women 
12 months 
Jorgensen
50
 82 11-17 100% 
parous 
Poor Poor Lippes 
loop, TCu 
N = 5 of 82 12 months 
Kulig, et al.
51
 120 13-22 81% 
nulliparou
s 
Poor Fair Copper-7 18% 36 months 
Lane and 
Sobrero
52
 
101 13-19 96% 
nulliparou
s 
Fair Poor Loop C, 
Loop D, 
LEM, W 
N = 21 9 months 
Larsson, et 
al.
53
 
179 15-19 Unclear Poor Poor Copper-7 12.9% 24 months 
Patchen and 
Berggren
54
 
39 15-21 100% 
parous 
Fair Poor TCu 380A 15% 24 months 
Paterson, et 
al.
55
 
133 10-19 N = 114 
nulligravid 
Fair Fair LNG-IUS N = 11 Not 
specified 
Sivin and 
Stern 
706 
465 
2280 
<20 Unclear Poor Fair TCu 380A 
TCu 220C 
TCu 200 
14.6/100 
12.6/100 
17.5/100 
24 months 
Weiner, et 
al.
57
 
243 13-20 100% 
nulligravid
ae 
Poor Poor TCu 200, 
Copper-7 
11.5% 6 months 
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Table 11. Continuation Rates. 
Citation N = ? Ages Parity Internal 
Validity 
External 
Validity 
IUDs 
used 
Continuati
on rate 
Timing 
Behringer, et 
al.
45
 
131 14-20 18.3% 
nulliparou
s 
Fair Fair LNG-IUS 80.9% 36 months 
Godfrey, et 
al.
46
 
12 
11 
14-18 12 
nulliparou
s 
Fair Fair LNG-IUS 
TCu 380A 
75% 
45% 
6 months 
Goldman, et 
al.
47
 
162 13-18 100% 
nulliparou
s 
Poor Poor Lippes 
loop A, 
Cu-7, TCu 
69.1% 12 months 
Goldman 
and 
Reichman
48
 
30 14-18 100% 
nulliparou
s 
Poor Poor Cu-7, TCu 73.3% 24 months 
Hirvonen 
and Kaivola
49
 
241 15-21 100% 
nulliparou
s 
Poor Poor Fincoid 73.1% 12 months 
Jorgensen
50
 82 11-17 100% 
parous 
Poor Poor Lippes 
loop, TCu 
88% 12 months 
Kulig, et al.
51
 120 13-22 81% 
nulliparou
s 
Poor Fair Copper-7 39% 36 months 
Lane and 
Sobrero
52
 
101 13-19 96% 
nulliparou
s 
Fair Poor Loop C, 
Loop D, 
LEM, W 
73.2% 9 months 
Larsson, et 
al.
53
 
179 15-19 Unclear Poor Poor Copper-7 77.2% 24 months 
Patchen and 
Berggren
54
 
39 15-21 100% 
parous 
Fair Poor TCu 380A 39% 24 months 
Paterson, et 
al.
55
 
133 10-19 N = 114 
nulligravid 
Fair Fair LNG-IUS 85% 12 months 
Sivin and 
Stern 
706 
465 
2280 
<20 Unclear Poor Fair TCu 380A 
TCu 220C 
TCu 200 
Not 
stratified 
by age 
24 months 
Weiner, et 
al.
57
 
243 13-20 100% 
nulligravid
ae 
Poor Poor TCu 200, 
Copper-7 
78.8% 6 months 
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DISCUSSION 
1. Interpretation of the Evidence 
The purpose of this systematic review was to determine the appropriateness of the IUD 
as a first-line contraceptive for adolescents in the United States.  Appropriateness was to be 
determined by the pregnancy rate, expulsion rate, and continuation rate.  The evidence 
obtained on data extraction presents a mixed picture, with a wide range for each of those three 
measures.  There was also discordance in the type of IUD used in the studies, with ten of the 
thirteen studies containing at least some IUDs not currently on the market in the U.S., and five 
of those containing no IUDs currently on the market in the U.S. 
2. Pregnancy Rate 
Eleven of the thirteen studies provided pregnancy rate within a specified time period.  
One retrospective cohort reported N = 0 for pregnancies in the study population, but did not 
provide a time period for this measure. 55  Another study did not assess pregnancy rate.45  Only 
one study with both “fair” internal and external validity reported pregnancy rate, with N = 1 out 
of 11 at 6 months for copper-T 380A IUD, and N = 0 out of 12 at 6 months for LNG-IUS.  The 
highest rate reported was 10% at 24 months.54  The studies in this review tended to have a 
small number of participants; only 4 had more than 150 participants, and thus the data for a 
relatively rare event (failure rate 0.8% per year and 0.2% per year for copper-T 380A and LNG-
IUS, respectively, found for all women) are more likely to be inaccurate.19,20  Fertility naturally 
declines with age after peaking in the early- to mid-twenties, and thus it may not be 
appropriate to use the pregnancy rates of older women on the same method of birth control as 
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a comparison for the pregnancy rates of adolescents and young women.58  It is deemed not 
possible to estimate the pregnancy rate for adolescents receiving the IUD based on the results 
of this systematic review.  
3. Expulsion Rate 
Twelve of the thirteen studies provided expulsion rate with a specified time period.  One 
retrospective cohort provided a number of expulsions but did not provide a denominator of a 
time period.55   The two studies with “fair” internal and external validity which measured 
expulsion rates reported rates of 9.9% at 36 months for the LNG-IUS and N = 0  of 12 at 6 
months and N = 2 of 11 at 6 months for the LNG-IUS and copper-T 380A, respectively.45,46  The 
expulsion rate overall ranged from 1.9 per 100 women to 18% in time periods from 6 months to 
36 months.  Given the heterogeneity of the devices used in terms of size as well as material and 
medication, and the small sizes of the studies, it is deemed that it is not possible to estimate 
the expulsion rate in adolescents at this time based on the results of this systematic review. 
4. Continuation rate 
 Twelve of the thirteen studies reported continuation rate within a specified time 
period.  The analysis of pooled data reported a continuation rate but did not stratify the rate by 
age.56  The three studies with an internal and external validity of “fair” reported continuation 
rates of 80.9% at 36 months, 75% (LNG-IUS) and 45% (copper-T) at 6 months, and 85% at 12 
months.45,46,55  The lowest reported continuation rates were 39% at 36 months and 39% at 24 
months, while the highest reported continuation rate was 88% at 12 months.51,54  As with the 
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data for pregnancy rate and expulsion rate, it is deemed that it is not possible to estimate the 
continuation rate of the IUD based on the results of this systematic review. 
5. Limitations of This Review and Overall Grade of Evidence 
As with any review of the literature, this review is subject to publication bias.  The main 
limitation of this review, however, was the quantity and quality of the available literature on 
the subject.  The inclusion criteria were extremely sensitive as opposed to specific, and even 
then only 13 studies were found to be suitable for review.  The study designs were a limiting 
factor, with only one randomized controlled trial found.  This study was extremely limited by 
sample size (N = 23), as were many of the other studies (albeit to a lesser extent), limiting their 
ability to accurately describe or compare pregnancy rates, given that pregnancy while using an 
IUD for contraception is a relatively rare event.   
Six of the studies included were descriptive rather than comparative studies, providing a 
lower level of evidence than comparative studies such as cohort studies or randomized 
controlled trials.  Additionally, the internal and external validity of the included studies were a 
strong limiting factor.  No studies had either a “good” internal validity or external validity, and 
only three studies had “fair” internal and external validity.  Thus, the overall grade of the 
evidence is deemed to be poor; the evidence found in this systematic review is not sufficient to 
make a definitive statement regarding acceptability of the IUD as a first-line contraceptive in 
adolescents at this time. 
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6. Future Directions 
Due to the nature of the intervention, it is likely not feasible to conduct large-scale 
randomized controlled trials comparing the IUD to other methods of contraception.  Blinding 
(unless it is blinding as to type of IUD) is relatively impossible and most likely unethical.  Thus, 
future studies could address this question through the use of prospective or retrospective 
cohort designs.  Retrospective cohort studies would have the advantage of being able to 
capture a much larger study population as compared to prospective cohort studies due to their 
lower cost.  Ideally, the cohort study would compare the IUD to current first-line contraception 
for adolescents, and the groups would be matched for a wide array of potential confounders, 
such as age, parity, gravidity, socioeconomic status, race, etc.  Cohort studies have an inherent 
advantage over case-series as they directly compare the measures of interest within the same 
setting and using the same analyses. 
Current opinions from the World Health Organization and the American Congress of 
Obstetricians and Gynecologists state that IUDs are appropriate first-line contraception for 
adolescents.  However, these practice guidelines are based on expert opinion, as the level of 
evidence is simply lacking on this important clinical subject.  As in a previous review of this 
topic, perhaps the most important finding of this systematic review is the overall lack of a 
meaningful quantity of high quality evidence.  A related and promising finding, however, was 
the emergence of a few new studies on this topic since the last systematic review.  Their 
improvement in quality compared to previous studies is also encouraging.    
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Appendix A. Data Abstraction Forms.  
Study 1 JAMA Citation: Behringer T, Reeves MF, Rossiter B, Chen BA, Schwarz EB. Duration of use of a 
levonorgestrel IUS amongst nulliparous and adolescent women Contraception. 2011;84(5):e5-e10. 
Country: United States 
Study Question: What are the rates and reasons for discontinuing LNG-IUS in adolescents compared to older women 
and nulliparous compared to parous women?  
Source of Funding: Doris Duke; NIH grants 
Source Population: Women aged 14-50 years seen in an academic clinic in Pittsburgh, PA and receiving an LNG-IUS for 
contraception, dysmenorrhea, or menorrhagia between June 2005 and April 2008 
Study Population: All women fitting criteria in retrospective medical chart review 
Age considered adolescent: 14-20 
Exclusion criteria: No information on parity; >50 
Design: Study design: Retrospective cohort 
Sample size: 131 adolescents (14-20), 697 adult women 
Intervention: Type of IUD? LNG-IUS 
Comparison: Adolescent vs. non-adolescent 
Potential for Selection Bias: Moderate 
Potential for sampling bias: 
Are there differences in adolescent vs. adult populations who utilize the academic medical center? 
Were the 36 subjects excluded due to lack of information on parity significantly different from study 
population? 
Population Characteristics: Parity: 18.3% nulliparous in adolescent group; 11.5% nulliparous in adult group 
Randomization? No 
Groups similar at baseline? No.  Statistically significant difference in race (p = 0.03), marital status (p < 
0.001), and parity (0.03); controlled for in analysis by interaction term for parity and age 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 36 months 
Cumulative expulsion rate? Yes 
--Timing? 36 months 
Continuation rate? Yes 
--Timing? 36 months 
Measurement Study groups: 
N = 131 adolescents <20 
N = 697 adult women 21-50 
 
Exposure meaures: Insertion recorded in medical record; age recorded in medical record 
Outcomes: IUS expulsion, IUS removal, method failure 
Outcome measures: Medical record review 
Potential for Measurement Bias: Low to moderate 
Trained research assistants abstracted relevant data from medical records 
Discontinuation may be underreported as patients could have had device removed at another clinic 
or self-removed 
Potential for Confounding: Moderate. 
No randomization was performed as this was a cohort study 
No data was provided about comparability in terms of socio-economic status 
The statistically significant differences in parity, race, and marital status were controlled for in the 
data analysis, with an interaction term included for parity and age 
Analysis: Primary: Women not seen following placement assumed to have continued use 
Secondary: Examined only those making 1+ follow-up visits 
Cox proportional hazard models in both scenarios controlled for age, race, and marital status; 
interaction term included to ensure that parity was not affecting outcome coefficients 
Kaplan-Meier curves created and log-rank tests performed to test for equality of time to IUS removal 
Chi-square and Fisher’s Exact Tests used to test associations
 
Results: Unintended pregnancy rate: Not measured 
Cumulative expulsion rate: 9.9% in adolescents, 5.2% in adults (p = 0.03) at 36 months 
Continuation rate: 80.9% in adolescents, 82.6% in adults at 36 months 
Attrition: Number of dropouts?  36 adolescents and 219 adults did not return to the study clinic after insertion 
(27.5% and 31.4%) 
Overall Judgment of Internal Validity 
(Quality Rating): 
Fair. 
External Validity: Fair.   
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Study 2 JAMA Citation: Godfrey EM, Memmel LM, Neustadt A, et al. Intrauterine contraception for 
adolescents aged 14-18 years: A multicenter randomized pilot study of levonorgestrel-releasing 
intrauterine system compared to the copper T 380A. Contraception. 2010;81(2):123-127. 
Country: United States 
Study Question: What are the rates of pregnancy, expulsion, continuation, infection, side effects, bleeding, and 
satisfaction for two FDA-approved IUC methods among 14-18 year old adolescents? 
Source of Funding: Anonymous foundation 
Source Population: 37 women 14-18 seen in Section of Family Planning in the Department of Obstetrics and Gynecology 
at the University of Chicago and the Department of Family Medicine at the University of Illinois-
Chicago seeking intrauterine contraception who reported regular menstrual cycles and desired long-
acting, reversible IUC approached regarding study 
Study Population: 23 of initial 37 eligible and randomized 
Age considered adolescent: 14-18 
Exclusion criteria: Known uterine or cervical anomaly, untreated cervical infection, pelvic infection 
within the past 3 months, previous IUC use, chronic disease (e.g., malignancy, liver or kidney disease), 
genital bleeding of unknown etiology or allergy to device ingredients 
Design: Study design: Randomized, single-blind (participant) controlled trial 
Sample size: 23 adolescents (11 copper T 380A, 12 LNG-IUS)  
Intervention: Type of IUD? LNG-IUS and copper T 380A 
Comparison: LNG-IUS vs. copper T 380A 
Potential for Selection Bias: Moderate to low 
11 refused screening visit (wanted to choose type of device, desired other birth control, did not meet 
inclusion criteria, not interested in study, parent/guardian refused consent); 3 excluded due to refusal 
to participate 
Unknown characteristics of those not selected vs. those selected 
Population Characteristics: Parity: 8 nulliparous in LNG-IUS, 4 nulliparous in CuT380A 
Randomization? Yes – 4 blocks with sets of 6; numbers in sealed, opaque envelopes, generated 
sequentially by statistician uninvolved in study 
Groups similar at baseline? Yes; however small size of study groups precluded use of statistical tests 
for significant differences 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 6 months 
Cumulative expulsion rate? Yes 
--Timing? 6 months 
Continuation rate? Yes 
--Timing? 6 months 
Measurement Study groups: 
N = 11 receiving copper T 380A 
N = 12 receiving LNG-IUS 
 
Exposure measures: Insertion as performed by study providers 
Outcomes: uterine perforations, removal, STI diagnosis, continuation rates, pregnancy rate, expulsion 
rate, removal rate, side effects, satisfaction  
Outcome measures: Clinical evaluation at study visits; side effects assessed via journal; satisfaction 
assessed via Likert scale at last visit 
Potential for Measurement Bias: Moderate to low 
Investigators and coordinators were not blinded to type of device inserted (participants were blinded 
to the device inserted) 
Outcome measures were not readily subjective  
Potential for Confounding: Moderate to low 
Randomization was performed 
However, due to the small size of the study groups, there was still some potential for confounding 
Analysis: Intention to treat (participants were included in originally assigned groups for assessment of 
outcomes)  
Results: Unintended pregnancy rate: 0 in LNG-IUS, 1 in copper T 380A at 6 months 
Cumulative expulsion rate: 0 in LNG-IUS, 2 in copper T 380A at 6 months 
Continuation rate: 75% (n = 9 of 12) in LNG-IUS, 45% (n = 5 of 11) in copper T 380 A 
Attrition: Number of dropouts?  2 in LNG-IUS, 2 in CuT380A 
Overall Judgment of Internal Validity 
(Quality Rating): 
Fair. 
External Validity: Fair. 
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Study 3 JAMA Citation: Goldman JA, Dekel A, Reichman J. Immediate postabortion intrauterine contraception 
in nulliparous adolescents. Isr J Med Sci. 1979;15(6):522. 
Country: Israel 
Study Question: What are the rates of expulsion, uterine bleeding, uterine contraction/pain, mild pelvic inflammation, 
discontinuation/removal, and pregnancy for adolescents receiving three different IUDs 
Source of Funding: Unknown 
Source Population: 300 pregnant teenagers referred for abortion and deemed to be of low intelligence and/or low 
motivation and with a primarily low socioeconomic background offered IUD contraception from two 
different clinics 
Study Population: 162 of those referred consented 
Age considered adolescent: 13-18 
Exclusion criteria: not stated 
Design: Study design: prospective cohort 
Sample size: 162 adolescents (56 Lippes loop A, 45 copper-7, 61 copper-T)  
Intervention: Type of IUD? Lippes loop A, copper-7, copper-T  
Comparison: Lippes loop A vs. copper-7 vs. copper-T 
Potential for Selection Bias: High 
Only about half of those deemed eligible by nebulous criteria consented to the study. 
None of the characteristics of those who refused to participate are available. 
Population Characteristics: Parity: 126 primigravid, 36 multigravid; all nulliparous 
Randomization? No 
No information regarding comparability of groups or method of selection of type of IUD 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 12 months 
Cumulative expulsion rate? Yes 
--Timing? 12 months 
Continuation rate? Yes 
--Timing? 12 months 
Measurement Study groups: 
N = 56 receiving Lippes loop A 
N = 45 receiving copper-7 
N = 61 receiving copper-T 
 
Exposure measures: Insertion as performed by study providers 
Outcomes: Expulsion of IUD, uterine bleeding, uterine contractions (or pain), mild pelvic 
inflammation, removal of IUD, dropout, pregnancy  
Outcome measures: Unclear for some measures of outcome (uterine bleeding, uterine contractions 
or pain, mild pelvic inflammation); likely clinical assessment otherwise 
Potential for Measurement Bias: High 
No blinding was performed 
The method of determining the clinical outcomes was not stated by the authors 
Potential for Confounding: High 
There is no information on the comparability of the groups, and the groups were not randomized. 
There is also no information on how the exposures (types of IUDs) were allocated 
Analysis: Chi-square test for significance 
Results: Unintended pregnancy rate: 4 for Lippes loop A, 1 for copper-7, 1 for copper-T at 12 months; 3.7% for 
all methods 
Cumulative expulsion rate: 11 for Lippes loop A, 3 for copper-7, 4 for copper-T at 12 months; 11.1% 
for all methods 
Continuation rate: 48.2% for Lippes loop A, 86.6% for copper-7, 75.4% for copper-T at 12 months; 
69.1% for all methods 
 
Statistically significant difference found for copper-7 and copper-T vs. Lippes loop A 
Attrition: Number of dropouts?  Not reported 
Overall Judgment of Internal Validity 
(Quality Rating): 
Poor. 
External Validity: Poor. 
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Study 4 JAMA Citation: Goldman JA, Reichman J. Contraception in the teenager. A comparison of four 
methods of contraception in adolescent girls. Isr J Med Sci. 1980;16(7):510.  
Country: Israel 
Study Question: What are the continuation rates, complications, and side effects of four types of contraception (OCP, 
IUD, condom, foam) in adolescent women? 
Source of Funding: Unknown 
Source Population: High-school students referred to a clinic or to private practitioners by their parents or school nurse 
following request for contraception 
Study Population: 160 “highly selected adolescents of high socioeconomic standing” 
Age considered adolescent: 14-18 
Exclusion criteria: not stated 
Design: Study design: prospective cohort 
Sample size: 160 adolescents (72 OCPs, 30 IUD, 38 condoms, 20 contraceptive foam)  
Intervention: Counseling on and access to contraceptive method (OCPs, IUD, condoms, contraceptive foam) 
Type of IUD? copper-7 or copper-T 
Comparison: OCPs vs. IUD vs. condoms vs. contraceptive foam 
Potential for Selection Bias: High 
Nothing stated as to how the adolescents stated to be “highly selected” were actually selected 
No demographic information given to compare the study population to the source population 
Population Characteristics: Parity: nulliparous  
Randomization? No 
No information regarding comparability of groups or method of selection of type of contraception 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 24 months 
Cumulative expulsion rate? Yes 
--Timing? 24 months 
Continuation rate? Yes 
--Timing? 24 months 
Measurement Study groups: 
N = 72 receiving OCPs 
N = 30 receiving IUD 
N = 38 advised to use condoms 
N = 20 receiving contraceptive foam 
 
Exposure measures: initiation of contraception and counseling as provided by study providers 
Outcomes: Expulsion of IUD, uterine bleeding, pain, pelvic inflammatory disease, side effects, 
reported cessation of contraception, pregnancy  
Outcome measures: Mild signs suggestive of salpingitis for pelvic inflammatory disease; nausea, fluid 
retention, breast tenderness, depression for side effects; these were most likely measured clinically, 
however it is not clear from the paper 
Potential for Measurement Bias: High 
No blinding was performed 
No information is available as to standardization of the counseling provided by the study providers 
The method of determining the clinical outcomes was not stated by the authors, and it is highly likely 
that these measures were subjectively obtained by the authors 
Potential for Confounding: High 
There is no information on the comparability of the groups, and the groups were not randomized. 
There is also no information on how the exposures (types of contraception) were allocated 
Analysis: Unspecified; likely chi-square test for significance 
Results: Unintended pregnancy rate: 0 for OCPs, 1 for IUD, 2 for condoms, 1 for foam at 24 months 
Cumulative expulsion rate: 2 for IUD at 24 months 
Continuation rate: 72% for OCPs, 73.3% for IUDs, 78.9% for condoms, and 15.8% for foam at 24 
months 
 
?statistical significance of difference in continuation rates at 24 months? 
Attrition: Number of dropouts?  Not reported 
Overall Judgment of Internal Validity 
(Quality Rating): 
Poor. 
External Validity: Poor. 
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Study 5 JAMA Citation: Hirvonen E, Kaivola S. A new copper IUD (fincoid) in adolescent and young nulliparous 
women. Contracept Deliv Syst. 1983;4:149. 
Country: Finland 
Study Question: What is the overall performance of a new copper IUD (Fincoid)?  
Source of Funding: Unknown 
Source Population: Nulliparous adolescents seen at an outpatient clinic in Helsinki in whom oral contraceptives had 
caused side-effects or were contraindicated 
Study Population: 241 women in whom the Fincoid was inserted 
Age considered adolescent: 15-21 
Exclusion criteria: not stated 
Design: Study design: case-series 
Sample size: 241 adolescents 
Intervention: Type of IUD? Fincoid 
Comparison: None 
Potential for Selection Bias: High 
No information given on how the patient population was selected  
No demographic information given to compare the study population to the source population 
Population Characteristics: Parity: nulliparous  
Randomization? No 
No information regarding comparability of groups or method of selection of participants from source 
population 
“Some” of the participants “occasionally forgot or were reluctant to take oral contraceptives” 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 12 months 
Cumulative expulsion rate? Yes 
--Timing? 12 months 
Continuation rate? Yes 
--Timing? 12 months 
Measurement Study groups: 
N = 241 receiving Fincoid 
 
Exposure measures: Insertion of IUD by study providers 
Outcomes: Accidental pregnancies, expulsions (total and partial), removals (with indications), 
continuation rate  
Outcome measures: Unclear. 
Potential for Measurement Bias: High 
The method of determining the clinical outcomes was not stated by the authors, and it is highly likely 
that these measures were subjectively obtained by the authors 
Also, the providers were aware of the intervention, and may have therefore been able to change the 
results based on desire to have the method succeed or fail  
Potential for Confounding: N/A 
Not a comparative study 
Analysis: Life table; rates calculated as per 100 women 
Results: Unintended pregnancy rate: 4.2 (± 1.5) per 100 women at 12 months 
Cumulative expulsion rate: 1.9 (± 0.9) total expulsions per 100 women at 12 months; 8.5 (± 1.9) partial 
expulsions per 100 women at 12 months 
Continuation rate: 73.1% at 12 months 
Attrition: Number of dropouts?  6.8 per 100 women at 12 months lost to follow-up 
Overall Judgment of Internal Validity 
(Quality Rating): 
Poor.  
External Validity: Poor. 
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Study 6 JAMA Citation: Jorgensen V. One-year contraceptive follow-up of adolescent patients. Am J Obstet 
Gynecol. 1973;115(4):484. 
Country: United States 
Study Question: What are the outcomes of different types  of contraception in adolescent women seen at a family 
planning clinic?  
Source of Funding: Grant from The Population Council, NY, NY 
Source Population: 221 “High risk” postpartum women seen in adolescent obstetrics and gynecology clinic (213 receiving 
OCPs in the interim from 5 days postpartum to 5 weeks postpartum) 
Study Population: 184 women returning to 5 week postpartum visit selecting either oral contraceptive, IUD, or 
diaphragm for contraception 
Age considered adolescent: 11-17 
Exclusion criteria: not stated 
Design: Study design: prospective cohort 
Sample size: 184 adolescents (90 OCPs, 80 IUD, 2 diaphragm) 
Intervention: Type of IUD? Lippes loop, copper T 
Comparison: OCPs vs. IUD vs. diaphragm 
Potential for Selection Bias: Moderate to high 
Patients self-selected method of contraception 
No information regarding comparability of groups in terms of socioeconomic status, race, etc. 
Population Characteristics: Parity: parous 
Randomization? No  
No information given regarding characteristics (race, socioeconomic status) of study population as 
compared to source population 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Not stratified by intervention 
--Timing? 12 months 
Cumulative expulsion rate? Yes 
--Timing? 12 months 
Continuation rate? Yes 
--Timing? 12 months 
Measurement Study groups: 
N = 90 selecting OCPs 
N = 82 selecting IUDs 
N = 2 selecting diaphragm 
 
Exposure measures: Insertion of IUD by study providers, prescription of OCPs, or prescription of 
diaphragm 
Outcomes: Continuation of contraception, expulsion  
Outcome measures: Office visits at 1, 3, 6, and 12 months 
Potential for Measurement Bias: Moderate to high 
The method of determining the clinical outcomes was not stated by the authors 
Also, the providers were aware of the intervention, and may have therefore been able to change the 
results based on desire to have the method succeed or fail  
Potential for Confounding: High 
No information available on comparability of groups 
Are those who choose IUD vs. condoms fundamentally different in a way that affects continuation 
rate, pregnancy rate, etc? (this is not as likely to affect expulsion rate) 
Analysis: None 
Results: Unintended pregnancy rate: 5 at 12 months (all methods) 
Cumulative expulsion rate: 5 at 12 months 
Continuation rate: 88% IUD vs. 70% OCPs  
Attrition: Number of dropouts?  86 (38%) 
Not much information given regarding characteristics of those who dropped out versus those who 
completed the study (72 with IUD vs. 63 on OCPs completed the 12 months) 
Overall Judgment of Internal Validity 
(Quality Rating): 
Poor.  No attention was given to confounders 
External Validity: Poor. 
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Study 7 JAMA Citation: Kulig JW, Rauh JL, Burket RL, Cabot HM, Brookman RR. Experience with the copper 7 
intrauterine device in an adolescent population. J Pediatr. 1980;96(4):746. 
Country: United States 
Study Question: What are the rates of continuation, expulsion, satisfaction, and pregnancy with copper-7 IUDs in an 
adolescent population?  
Source of Funding: Not specified 
Source Population: Adolescent patients seen from 1974-1978 in the Cincinnati Adolescent Clinic choosing an IUD for 
contraception 
Study Population: 120 consecutive patients from July 1974 to June 1978 
Age considered adolescent: 13-22 
Exclusion criteria: “medical contraindications to Cu-7” (not specified); patients unwillingness to retain 
the device and/or return for follow-up 
Design: Study design: case-series 
Sample size: 120 adolescent patients with 137 total insertions  
Intervention: Type of IUD? Copper-7  
Comparison: N/A 
Potential for Selection Bias: Moderate to high 
Patients self-selected method of contraception 
Not clear how study population compares to source population (i.e., are there important differences 
between women who choose an IUD  vs. those who choose OCPs and other methods?) 
Population Characteristics: Parity: 81% nulliparous, 16% primiparous, 3% multiparous 
Randomization? N/A 
58% black/42% white 
“generally urban” 
Predominantly from “lower socioeconomic areas” 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 36 months 
Cumulative expulsion rate? Yes 
--Timing? 36 months 
Continuation rate? Yes 
--Timing? 36 months 
Measurement Study groups: 
N = 120 selecting IUD for contraception 
 
Exposure measures: Insertion of IUD by study providers 
Outcomes: Continuation of contraception, side effects, removal, expulsions, pregnancy rate  
Outcome measures: Office visits at 3 weeks post-insertion, and every three months after initial post-
insertion visit 
Potential for Measurement Bias: Moderate to high 
The methods of determining the clinical outcomes were  not stated by the authors 
Also, the providers were aware of the intervention, and may have therefore been able to change the 
results based on desire to have the method succeed or fail 
It is not clear that the measurements were performed in an equal, valid, and reliable fashion 
Potential for Confounding: N/A 
No comparison was made 
Analysis: N/A 
Results: Unintended pregnancy rate: 3 of 120 at 36 months  (2.0 per 100 woman-years of IUD insertion) 
Cumulative expulsion rate: 18% overall (n = 21 of 116) at 36 months; 22% for parous (n = 5 of 22) at 
36 months; 17% for nulliparous (n = 16 of 94) 
Continuation rate: 39% at 36 months  
Attrition: Number of dropouts?  4 (3%) 
No information regarding characteristics of dropouts 
Overall Judgment of Internal Validity 
(Quality Rating): 
Poor. 
External Validity: Fair. 
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Study 8 JAMA Citation: Lane ME, Sobrero AJ. Experience with intrauterine contraception by adolescent 
women. Mt Sinai J Med. 1975;42(4):337. 
Country: United States 
Study Question: Purpose: to “describe the experience of the Margaret Sanger Research Bureau with the provision of 
IUD to clients of its Teen Center” 
Source of Funding: Funded in part by grants from The Population Council, NY, NY 
Source Population: 399 adolescent patients seen at the Margaret Sanger Teen Center from 3/1/1971-12/31/1972 
Study Population: 101 patients who selected the IUD as their contraceptive method 
Age considered adolescent: 13-19 
Exclusion criteria: “medical contraindication” (not specified); “high level of anxiety” regarding 
insertion 
Design: Study design: case-series 
Sample size: 101 adolescents with 130 total IUD insertions  
Intervention: Type of IUD? Loop C, Loop D, LEM, W  
Comparison: N/A- intent of report was not to analyze performance of devices by type 
Potential for Selection Bias: Moderate 
Patients self-selected method of contraception 
Not clear how study population compares to source population (i.e., are there important differences 
between women who choose an IUD  vs. those who choose OCPs and other methods?) 
Population Characteristics: Parity: 96% nulliparous; 83% nulligravid 
Randomization? N/A 
Median age 16 years 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 9 months 
Cumulative expulsion rate? Yes 
--Timing? 9 months 
Continuation rate? Yes 
--Timing? 9 months 
Measurement Study groups: 
N = 101 patients selecting IUD for contraception with 130 total IUD insertions (2 W, 54 LEM, 44 Loop 
C, and 1 Loop D on first insertion; 2 W, 1 LEM, 13 Loop C, and 13 Loop D on reinsertion) 
 
Exposure measures: Insertion of IUD by study providers (85% by two attending physicians, with the 
other 15% by medical fellows and one family planning nurse practitioner) 
Outcomes: Accidental pregnancy, expulsion, removal (as well as reason), discomfort of insertion 
Outcome measures: Office visits at 4 weeks post-insertion, and at least every three months after 
initial post-insertion visit 
Potential for Measurement Bias: Moderate 
Exposure measurement was likely equal, valid, and reliable, with two physicians performing the 
majority (85%) of insertions 
The methods of determining the clinical outcomes were  not stated by the authors 
Also, the providers were aware of the intervention, and may have therefore been able to change the 
results based on desire to have the method succeed or fail 
Potential for Confounding: N/A 
No comparison was made 
Analysis: N/A 
Results: Unintended pregnancy rate: n = 4 of 101 at 9 months 
Cumulative expulsion rate: n = 21 of 101 at 9 months 
Continuation rate: n = 73.2% at 9 months  
Attrition: Number of dropouts?  8 (7 lost to follow-up, 1 released to another source of care) 
No information regarding characteristics of dropouts 
Overall Judgment of Internal Validity 
(Quality Rating): 
Fair 
External Validity: Poor 
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Study 9 JAMA Citation: Larsson B, Hagström B, Viberg L, Hamberger L. Long-term clinical experience with the 
Cu-7-IUD. Evaluation of a prospective study. Contraception. 1981;23(4). 
Country: Sweden 
Study Question: Objective: Evaluate compiled data of prospective study of copper-7 IUD 
Source of Funding: No information given 
Source Population: Women receiving contraception at a private clinic in Stockholm or two family planning centers in 
Huddinge from 1971-1979 
Study Population: 1446 women 
Age considered adolescent: subgroup analysis of age group 15-19 
Exclusion criteria: Not available 
Design: Study design: prospective cohort 
Sample size: 179 women 15-19; 444 women 20-24; 518 women 25-29; 128 women 30-34; 134 women 
35-39; 43 women 40-49  
Intervention: Type of IUD? Copper-7  
Comparison: Based on age groups 
Potential for Selection Bias: High 
Unclear how method of contraception was selected, or how study population was selected 
Not clear how study population compares to source population 
Population Characteristics: Parity: unknown for age strata; overall n = 699 nulligravidae, 59 nulliparae, 337 parous x 1, 351 parous 
x 2+  
Randomization? N/A 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 24 months 
Cumulative expulsion rate? Yes 
--Timing? 24 months 
Continuation rate? Yes 
--Timing? 24 months 
Measurement Study groups: 
N = 179 women 15-19 
N = 444 women 20-24 
N = 518 women 25-29 
N = 128 women 30-34 
N = 134 women 35-39 
N = 43 women 40-49 
 
Exposure measures: Insertion of IUD by study providers (two physicians at private clinic = 665 women; 
“several doctors and midwives” at family planning clinics)  
Outcomes: Accidental pregnancy, expulsion, removal (as well as reason), salpingitis, bleeding/pain, 
planned pregnancy 
Outcome measures: Unclear 
Potential for Measurement Bias: High 
The methods of determining the clinical outcomes were  not stated by the authors 
Also, the providers were aware of the intervention, and may have therefore been able to change the 
results based on desire to have the method succeed or fail for a given outcome for a particular 
subgroup 
Potential for Confounding: High 
No information given regarding comparability of different age groups (e.g., marital status, education 
level, socioeconomic status, etc.)  
Analysis: Chi-square test, Fisher’s exact test 
Results: Unintended pregnancy rate: n = 11 (6.1%) at 24 months for 15-19; higher, but not statistically 
significantly different than other age groups 
Cumulative expulsion rate: n = 23 (12.9%) at 24 months for 15-19; statistically significantly higher than 
expulsions for other groups 
Continuation rate: 77.2% at 24 months 
Attrition: Number of dropouts?  135 women lost to follow-up; unclear how many from each group 
No information regarding characteristics of dropouts 
Overall Judgment of Internal Validity 
(Quality Rating): 
Poor.  No adjustment for confounding or attempt to describe characteristics of study groups beyond 
age 
External Validity: Poor. 
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Study 10 JAMA Citation: Patchen L, Berggren EK. Use of the copper T380A intrauterine device by adolescent 
mothers: Continuation and method failure J Pediatr Adolesc Gynecol. 2011;24(2):71-73. 
Country: United States 
Study Question: Objective: To contribute to limited empirical data regarding the use of copper-T 380A IUD among 
parous adolescents 
Source of Funding: NICHD grants, Center on Health and Education and Department of Human Science in the School of 
Nursing and Health Studies at Georgetown University 
Source Population: 318 adolescent mothers aged 15-21 (who had delivered prior to age 18) while participating in a teen 
secondary pregnancy prevention program 
Study Population: 39 women 
93% Hispanic 
Age considered adolescent: 15-21 
Exclusion criteria: older than 21 at IUD insertion, nulliparous 
Design: Study design: retrospective case-series 
Sample size: 39 women 
Intervention: Type of IUD? Copper-T 380A 
Comparison: N/A 
Potential for Selection Bias: Moderate 
Unclear how method of contraception was selected 
Not clear how study population compares to source population 
However, all charts within the source population were reviewed 
Population Characteristics: Parity: parous 
Randomization? N/A 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 24 months 
Cumulative expulsion rate? Yes 
--Timing? 24 months 
Continuation rate? Yes 
--Timing? 24 months 
Measurement Study groups: 
N = 39 women receiving copper-T 380A IUD 
 
Exposure measures: Chart review 
Outcomes: Accidental pregnancy, expulsion, removal (as well as reason), salpingitis, bleeding/pain, 
planned pregnancy 
Outcome measures: Chart review 
Potential for Measurement Bias: Moderate 
The methods of determining clinical outcomes were explicitly stated 
Providers were aware of the intervention, and may have therefore been able to change the results 
based on desire to have the method succeed or fail for a given outcome 
Chart review was not blinded 
Potential for Confounding: N/A 
No comparison made 
Analysis: N/A 
Results: Unintended pregnancy rate: n = 4 (10%) at 24 months 
Cumulative expulsion rate: n = 6 (15%) at 24 months  
Continuation rate: 39% at 24 months 
Attrition: Number of dropouts?  72% with complete follow-up data to termination of IUD use or 24 months 
Overall Judgment of Internal Validity 
(Quality Rating): 
Fair. 
External Validity: Poor.  Sample size is very small and likely not indicative of overall U.S. primary care population. 
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Study 11 JAMA Citation: Paterson H, Ashton J, Harrison-Woolrych M. A nationwide cohort study of the use of 
the levonorgestrel intrauterine device in new zealand adolescents Contraception. 2009;79(6):433-438. 
Country: New Zealand 
Study Question: Objective: To “determine the indications for insertion of the LNG-IUD in New Zealand adolescents … 
and to establish patterns of use, including duration of use of the LNG-IUD in the adolescent 
population and reasons for removal.” 
Source of Funding: No external funding source 
Source Population: Adolescent women in New Zealand ages 10-19 receiving the LNG-IUS 
Study Population: 177 adolescent women identified through Intensive Medicine Monitoring Program (IMMP) as having 
received the IUD  175 (insertion population)  133 questionnaires completed (responder 
population) 
Age considered adolescent: 10-19 
Exclusion criteria: deceased, records not available through New Zealand Health Information Service 
(NZHIS); device not actually inserted 
Design: Study design: retrospective case-series 
Sample size: 133 women 
Intervention: Type of IUD? LNG-IUS  
Comparison: N/A 
Potential for Selection Bias: Moderate 
Large-scale database which should identify most cases 
Not clear how responder population compares to insertion population or source population 
Population Characteristics: Parity: n = 114 nulligravid 
Randomization? N/A 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? No reported pregnancies, but study not powered to assess unplanned 
pregnancy rate 
--Timing? N/A 
Cumulative expulsion rate? “cumulative incidence” 
--Timing? Unclear 
Continuation rate? Yes 
--Timing? 12 months 
Measurement Study groups: 
N = 133 women receiving LNG-IUS deemed to be part of the “responder population” 
 
Exposure measures: Chart review, questionnaire to provider; characteristics for provider inserting the 
IUS were available 
Outcomes: Comorbidities reported with insertion, removal, indications for removal (including 
expulsion)  
Outcome measures: Chart review (NZHIS), questionnaire to provider 
Potential for Measurement Bias: Moderate 
Chart review and questionnaire completion were not blinded 
Potential for Confounding: N/A 
No comparison made 
Analysis: Product-limit survival estimates; gross discontinuation rates estimated at 1 year following insertion of 
LNG-IUS 
Results: Unintended pregnancy rate: n = 0; no time period specified 
Cumulative expulsion rate: n =11 
Continuation rate: 85% at 12 months 
Attrition: Number of dropouts? N/A, retrospective chart review 
Overall Judgment of Internal Validity 
(Quality Rating): 
Fair. 
External Validity: Good.  Broad assessment of LNG-IUS in adolescents in a developed nation. 
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Study 12 JAMA Citation: Sivin I, Stern J. Long-acting, more effective copper T IUDs: A summary of U.S. 
experience, 1970-75. Stud Fam Plann. 1979;10(10). 
Country: United States 
Study Question: Objective: To assess the characteristics of 3 different types of copper-T IUDs, including pregnancy 
rates, expulsion rates, and continuation rates. 
Source of Funding: Not specified 
Source Population: Women in the United States receiving a copper IUD 
Study Population: Women receiving either the copper-T 200, copper-T 380A, and copper-T220C in one of 42 studies 
Age considered adolescent: <20 
Exclusion criteria: women in studies with >30% loss to follow-up were excluded 
Design: Study design: pooled data from random assignment and cohort studies 
Sample size: 3,536 accepting copper-T 380A; 1850 accepting copper-T 220C; 9,838 accepting copper-T 
200 
Intervention: Type of IUD? Copper-T 380A; copper-T 220C; copper-T 200  
Comparison: Copper-T 380A vs. copper-T 220C vs. copper-T 200 
Potential for Selection Bias: High 
No information regarding how participants were initially selected for the study, or information on 
how they relate to the source population 
Population Characteristics: Parity: no information regarding parity of <20 subgroup; 42.8% of TCu 200 acceptors; 63.7% of TCu 
380A acceptors, and 70.3% of TCu 220C acceptors were nulliparous 
Randomization? Double-blind randomization in some constituent studies 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 24 months 
Cumulative expulsion rate? Yes 
--Timing? 24 months  
Continuation rate? Not stratified by age 
--Timing? N/A 
Measurement Study groups: 
N = 706 women <20 receiving TCu 380A 
N = 2830 women >20 receiving TCu 380A 
N = 465 women <20 receiving TCu 220C 
N = 1385 women >20 receiving TCu 220C 
N = 2280 women <20 receiving TCu 200 
N = 7558 women >20 receiving TCu 200 
 
Exposure measures: based on report from 42 studies; exposure measured with regard to timing of 
insertion 
Outcomes: Pregnancy, expulsion, removal for medical reasons, removal for personal reasons, 
continuation  
Outcome measures: based on report from 42 studies; visits typically 1, 3, 6, 12 months post-insertion 
and every 12 months thereafter 
Potential for Measurement Bias: Moderate to high 
Possibility of interpretation of results meant to skew towards a particular outcome as this is 
secondary analysis of other studies 
Not clear that there is homogeneity in assessing outcomes 
Potential for Confounding: High 
No assessment of or correction for confounding variables 
Analysis: Tietze method of analysis 
Results: Unintended pregnancy rate: in women <20 at 24 months: 1.0 per 100 acceptors for TCu 380A; 2.2 per 
100 acceptors for TCu 220C; 6.6 per 100 acceptors for TCu 200 
Cumulative expulsion rate: in women <20 at 24 months: 14.6 per 100 acceptors for TCu 380A, 12.6 
per 100 acceptors for TCu 220C, 17.5 per 100 acceptors for TCu 200  
Continuation rate: not stratified by age  
Attrition: Number of dropouts? <30% for all studies 
Overall Judgment of Internal Validity 
(Quality Rating): 
Poor 
External Validity: Fair 
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Study 13 JAMA Citation: Weiner E, Berg AA, Johansson I. Copper intrauterine contraceptive devices in 
adolescent nulliparae. Br J Obstet Gynaecol. 1978;85(3):204. 
Country: Sweden 
Study Question: Objective: Report on the clinical outcomes of 243 nulligravidae receiving copper IUCDs 
Source of Funding: Not specified 
Source Population: 772 women in Sweden aged 13-20 seeking contraception at the Department of School Health in 
Uppsala, Sweden from 3/1973-6/1975 
Study Population: 243 patients who elected to get IUCD 
Age considered adolescent: 13-20 
Exclusion criteria: Not specified 
Design: Study design: Prospective case-series 
Sample size: 243 patients 
Intervention: Type of IUD? Copper-T 200 and copper-7 
Comparison: N/A 
Potential for Selection Bias: High 
No information regarding comparability of study population to source population 
Unclear whether the source population was composed of solely nulligravidae or only study population 
Population Characteristics: Parity: All were nulligravidae 
Randomization? N/A 
Outcome Assessment: Primary outcome measures: 
Unintended pregnancy rate? Yes 
--Timing? 6 months 
Cumulative expulsion rate? Yes 
--Timing? 6 months  
Continuation rate? Yes 
--Timing? 6 months 
Measurement Study groups: 
N = 243 women who had copper IUDs inserted 
 
Exposure measures: Insertion as performed by clinic gynecologist 
Outcomes: Pregnancy, expulsion, removal for medical reasons, removal for personal reasons, 
continuation, Pearl index 
Outcome measures: Based on return visit to clinic; unclear how outcomes were specifically measured 
Potential for Measurement Bias: Moderate to high 
No blinding of participants or investigators to the intervention 
No standardized method of assessment of outcomes is mentioned; it is not clear exactly how the 
outcomes were measured 
Potential for Confounding: N/A 
Analysis: None 
Results: Unintended pregnancy rate: N = 5 of 243 (2%) at 6 months 
Cumulative expulsion rate: N = 28 of 243 (11.5%) at 6 months 
Continuation rate: 78.8% at 6 months 
Attrition: Number of dropouts? 17 of 243 (7%) at 6 months  
Overall Judgment of Internal Validity 
(Quality Rating): 
Poor. 
External Validity: Poor. 
 
 
